A growing number of studies have demonstrated that sPD-L1 might play a crucial role in the prediction of the treatment response of PD-1/PD-L1 inhibitors and also the prognosis of cancer patients (17, 20, 21, 24). The gene discussed is SPDL1; the disease is cancer.